NATALIE RADLOFF: Open Payments
NPI 1518512409 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 119 payments from 17 companies in 2025. Trend: 2023 $355 · 2024 $726 · 2025 $2,049
Food & beverage: $1,697Education: $352
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $412 |
| ABBVIE INC. | 35 | $403 |
| Incyte Corporation | 11 | $229 |
| Galderma Laboratories, L.P. | 15 | $189 |
| GENZYME CORPORATION | 9 | $173 |
| LEO Pharma Inc. | 13 | $162 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 1 | $42 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, NEMLUVIO, ADBRY, RINVOQ, ANZUPGO.
Industry payments across AZ — which companies pay providers there.
